fingolimod hydrochloride has been researched along with Dengue in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernanda Mendes, M; Fragoso, YD; Gama, PDD; Gomes, S; Khouri, JMN; Matta, APDC; Stella, CRAV | 1 |
1 other study(ies) available for fingolimod hydrochloride and Dengue
| Article | Year |
|---|---|
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
Topics: Adult; Brazil; Dengue; Female; Fingolimod Hydrochloride; Humans; Immunologic Factors; Male; Multiple Sclerosis; Natalizumab; Severity of Illness Index | 2016 |